Wells Fargo’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Wells Fargo’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-2,000	Closed	-$13K	–	6118
2013 Q2	$13K	Buy	+2,000	New	+$12K	﹤0.01%	5001

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Wells Fargo's PBTH Position: Q3 2013 in Review

Wells Fargo sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 2,000 shares — an estimated $13K sold.

Wells Fargo first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $13K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Wells Fargo reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Wells Fargo sold 2,000 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $13K.
Wells Fargo first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Wells Fargo's PROLOR Biotech, Inc. Common Stock position peaked at $13K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Wells Fargo's 13F filing for Q3 2013, filed 13 Nov 2013.